about
Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis.Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study.Global impact of rotavirus vaccines.Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study.Prevention and treatment of viral diarrhea in pediatrics.Oral rotavirus vaccines: how well will they work where they are needed most?Rotavirus genotype distribution after vaccine introduction, Rio de Janeiro, Brazil.Group A rotavirus genotypes and the ongoing Brazilian experience: a review.Effectiveness of rotavirus vaccine in preventing hospitalization due to rotavirus gastroenteritis in young children in Connecticut, USA.Rotavirus disease and vaccination: impact on genotype diversity.Effect of monovalent rotavirus vaccine on rotavirus disease burden and circulating rotavirus strains among children in Morocco.Diversity of rotavirus strains circulating in children under 5 years of age admitted to hospital for acute gastroenteritis in Morocco, June 2006 to May 2009.Monitoring the circulation of rotavirus among children after the introduction of the Rotarix™ vaccine in Goiânia, Brazil.Rotavirus genotyping in gastroenteritis cases of an infantile population from Western Brazilian Amazonia.Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines.Molecular evolution of the VP7 gene of Japanese G2 rotaviruses before vaccine introduction.Rotavirus G9P[4] in 3 countries in Latin America, 2009-2010.Rotarix in Japan: Expectations and ConcernsRotavirus P[4]G2 in a Vaccinated Population, Brazil.The rotavirus experience in Mexico: discovery to control.The occurrence of amino acid substitutions D96N and S242N in VP7 of emergent G2P[4] rotaviruses in Nepal in 2004-2005: a global and evolutionary perspectiveCirculating rotavirus G and P strains post rotavirus vaccination in Eastern Mediterranean Region
P2860
Q33883799-A5C9EA96-94D9-43EA-B4B6-52005CCAB7BCQ33915516-F6116E6A-5BB8-4FD4-92F8-30067A2CCF21Q34108591-2DDDE3FE-212C-4083-8E4F-1AA0090A3928Q34146235-B81518BA-584B-433C-926F-0013974FED14Q34616273-EC73EA54-837B-4C47-91C3-60E7C51AB807Q36903971-22724BC9-ED08-463C-9C56-79F798061CFDQ37139895-F0430EB8-1E0A-40E9-AFDD-2A07D49EF0F2Q37369942-6101B24E-7D89-47E2-A017-6233A61F4490Q37452293-E15EAC60-DA66-4631-8FC7-3144AB50B254Q37648707-7EABB5FB-EA87-4BBB-B5AE-3C5E550BE7A8Q38903517-91D2115F-C857-4382-88E0-CA30C0CDBF8BQ38903522-6418B907-2456-4FC0-A438-931F32DD4E21Q38915064-F3F35168-89A7-4971-9DA4-F111DE726D32Q38954207-8AD9DDCB-7661-48B0-B91B-E576DE466D42Q40693674-0ADCBD30-3D12-491C-AC3E-F583EA39B5DFQ42278248-536A2028-2C92-4B68-9AEF-88D4448C9663Q42548720-21C337E6-8404-45CA-9A90-D7D0A2072B79Q42775398-A9A0E554-403A-4C66-9E67-3E13770A5E60Q45850756-3484CA4A-A4F1-4E30-ABC6-C208F8F5A8C5Q46678108-7A30431D-8BAD-4F72-9259-E730B8EAF589Q57530932-CA9CBF9C-5029-423D-8828-42110AF705CDQ57921832-3E8F8EB8-67EB-41B9-B871-E8DE302E5935
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Rotavirus P[4]G2 in a vaccinated population, Brazil.
@en
Rotavirus P[4]G2 in a vaccinated population, Brazil.
@nl
type
label
Rotavirus P[4]G2 in a vaccinated population, Brazil.
@en
Rotavirus P[4]G2 in a vaccinated population, Brazil.
@nl
prefLabel
Rotavirus P[4]G2 in a vaccinated population, Brazil.
@en
Rotavirus P[4]G2 in a vaccinated population, Brazil.
@nl
P2093
P2860
P356
P1476
Rotavirus P[4]G2 in a vaccinated population, Brazil.
@en
P2093
Ana Maria Bispo
Jon Gentsch
Lucia Helena de Oliveira
Manish M Patel
P2860
P304
P356
10.3201/EID1405.071440
P577
2008-05-01T00:00:00Z